Navigation Links
Neuralstem Receives FDA Approval to Commence First ALS Stem Cell Trial
Date:9/21/2009

ls or clearances, need for future capital, dependence upon collaborators and maintenance of our intellectual property rights. Actual results may differ materially from the results anticipated in these forward- looking statements. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in Neuralstem's periodic reports, including the annual report on Form 10-K for the year ended December 31, 2008 and the quarterly report on form 10-Q for the period ended June 30, 2009.


'/>"/>
SOURCE Neuralstem, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Neuralstem Shares Accepted for Trading on Amex(R)
2. American Stock Exchange Lists The Common Stock Of Neuralstem, Inc.
3. Patent Office Rules in Neuralstems Favor in Dispute with StemCells, Inc.
4. Neuralstem Inc. Announces Strategic Investment by Korean CJ CheilJedang Corporation
5. Neuralstem Sues StemCells, Inc. Over New Patent
6. Neuralstem Responds to New StemCells, Inc. Lawsuit
7. Neuralstem Fills Key Product Development Position
8. Neuralstem Reports Second Quarter Financial Results and Highlights
9. Neuralstem CEO to Speak on ALS Panel at World Stem Cell Summit
10. Neuralstem Receives Final Notice of Allowance for New Stem Cell Immortalization Technology Patent
11. Neuralstem to Present at the 11th Annual BIO CEO & Investor Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...nored by latest award for revolutionary hearing ai...ovember 16, 2009 -- Popular Science Magazine has n... from InSound Medical a winner of its coveted Best...    Chosen from thousands of e...earing canal for up to four months while providing...
(Date:11/18/2009)...f Standards and Technology (NIST) has demonstrated...ting and measuring elusive hazards such as conceal...od or pesticides distributed in soil by wind and r...onventional techniques for detecting traces of the... having distinct electrically positive and negativ...
(Date:11/18/2009)...ast are developing new sensors to detect chemical ...ght against the threat of terrorist attacks. , T... individual or crime scene to gather a sample whic...an detect the presence of chemicals within seconds...ade in response to terrorist threats. , The sca...
(Date:11/18/2009)...ewswire-FirstCall/ -- Masimo (Nasdaq: MASI ), t...hrough Motion and Low-Perfusion pulse oximetry, an...e of the largest healthcare Group Purchasing Organ...purchasing agreement for "gold standard" Masimo SE...referred contract pricing to Uni.H.A.,s 53 member ...
Breaking Biology Technology:Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 3Prototype NIST method detects and measures elusive hazards 2New technology detects chemical weapons in seconds 2Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 2Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 3Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 4
...edical, Inc.,(Nasdaq: ATSI ), manufacturer and ma...s and services, today announced it has obtained ne...racteristics of the ATS Open,Pivot(R) Mechanical H...in/prnh/20040202/ATSILOGO ), The first ATS Open P...on May 4, 1992 by Professor H. Sadeghi and Dr. Dem...
...llCyte Genetics,Corporation (CellCyte) (OTC Bullet...p) to provide strategic investment and financial a...older value by monetizing its two,core platform te...corporate,partnering strategy to exploit developme...er and stem cell delivery technologies., "We are ...
...inhua-PRNewswire/ -- WuXi PharmaTech (NYSE:,WX), a... device research,and development outsourcing compa... today proudly announced that Ms. Trabue D. Bryans...c,s Atlanta Operations, one of the U.S.,operating ... been invited,to join the Association for the Adva...
Other Biology Technology:ATS Medical Confirms Excellent Durability of the ATS Open Pivot Mechanical Heart Valve 2CellCyte Genetics Retains InCap Group to Advise on Business Strategy and Financing 2CellCyte Genetics Retains InCap Group to Advise on Business Strategy and Financing 3CellCyte Genetics Retains InCap Group to Advise on Business Strategy and Financing 4WuXi AppTec VP and GM Invited to Join the AAMI Standards Board 2WuXi AppTec VP and GM Invited to Join the AAMI Standards Board 3
(Date:11/20/2009)...arch report published in the November 2009 issue o... ), scientists show how a family of genes (1-amino... are responsible for production of ethylene. This ... this information lays the foundation for future g... resistant, able to survive and thrive in difficul...
(Date:11/20/2009)...ago, a group of University of Oklahoma researchers...t of the human genome project. Today, the OU Adv... to an international effort to sequence the tomato...ational Science Foundation for plant genomics. , ...e, so improving the tomato and crop yields will im...
(Date:11/20/2009)...question in the origin of biological molecules lik...ions of years ago from simple precursors. Now, in ...in Italy have reconstructed one of the earliest ev...A from individual subunits using nothing but warm ...one of the first biological molecules present, bef...
Breaking Biology News(10 mins):It's a gas: New discovery may lead to heartier, high-yielding plants 2NSF awards $7.5M grant to University of Oklahoma for plant genomics 2Elsevier announces launch of Spatial and Spatio temporal Epidemiology 59517 1Elsevier announces launch of Spatial and Spatio temporal Epidemiology 59517 2New mathematical model more accurately diagnoses acute heart failure in emergency rooms 59514 1New mathematical model more accurately diagnoses acute heart failure in emergency rooms 59514 2KINAXO Biotechnologies and Bayer Vital GmbH Collaborate in Phosphoproteomics Biomarker Identification 10371 1KINAXO Biotechnologies and Bayer Vital GmbH Collaborate in Phosphoproteomics Biomarker Identification 10371 2KINAXO Biotechnologies and Bayer Vital GmbH Collaborate in Phosphoproteomics Biomarker Identification 10371 3KINAXO Biotechnologies and Bayer Vital GmbH Collaborate in Phosphoproteomics Biomarker Identification 10371 4
...ment of more effective therapies for individuals w...blood cell cancer. The research, published by Cell...ell, provides new insight into the molecular mecha...n MM tumor cells and underscores the relevance of ...M therapy. , MM is a cancer of the plasma cell, a...
...heir ultrasonic echolocation calls to recognise th...geography by Danilo Russo and colleagues suggests ... (Rhinolophidae). These bats find their way in the...asound calls mainly made of a constant frequency. ...ency values. It has been proposed that such differ...
...ciety (ACS) News Service Weekly PressPac with news... Engineering News. ,Please credit the individual j...rce for this information. , ,ACS NEWS SERVICE ...MMEDIATE USE EXCEPT ARTICLE #5, which is embargoed... NOTE TO JOURNALISTS: Special editions of the Au...
Other Biology News:Diverse genetic abnormalities lead to NF-κB activation in multiple myeloma 2A 'private bandwidth' for communication in bats: Evidence from insular horseshoe bats 2American Chemical Society's Weekly PressPac -- Aug. 8, 2007 2American Chemical Society's Weekly PressPac -- Aug. 8, 2007 3American Chemical Society's Weekly PressPac -- Aug. 8, 2007 4American Chemical Society's Weekly PressPac -- Aug. 8, 2007 5American Chemical Society's Weekly PressPac -- Aug. 8, 2007 6American Chemical Society's Weekly PressPac -- Aug. 8, 2007 7American Chemical Society's Weekly PressPac -- Aug. 8, 2007 8American Chemical Society's Weekly PressPac -- Aug. 8, 2007 9
... Rabbit polyclonal to Kv4.2 Immunogen Synthetic ... corresponding to amino acids 23-43 of Rat Kv4.2. ...xpected to cross-react with Human (100% identity w...n), Rabbit (100% identity with immunogen) and Ferr...
...oclonal [198C679.2.1] to Presenilin 2 Alzheimer's...he disease carry mutations in the presenilin prote...n (APP). These disease-linked mutations result in ...-beta (main component of amyloid deposits found in...
XTT (23-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide) from Molecular Probes (Invitrogen)
2-Fluorine-CTP (2-F-CTP) from EPICENTRE Biotechnologies
Biology Products: